Vaccine adjuvants: mechanisms and platforms

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Adjuvants are essential vaccine components, but their mechanisms of action are not fully understood.
• Recent advances in innate immunity research are clarifying how adjuvants enhance antigen-specific responses.
• Adjuvants are broadly classified into immunostimulants and delivery systems.

Purpose of the Study:

• To systematically review the action mechanisms of vaccine adjuvants.
• To introduce the mechanisms, properties, and progress of classical vaccine adjuvants.
• To summarize novel adjuvant platforms and their potential for rational vaccine design.

Main Methods:

• Literature review and synthesis of existing research on vaccine adjuvants.
• Categorization of adjuvants into immunostimulants and delivery systems based on their function.
• Analysis of mechanisms, properties, and immunological potential of classical and novel adjuvants.

Main Results:

• Immunostimulants activate antigen-presenting cells (APCs) via pattern recognition receptors (PRRs), enhancing adaptive immunity.
• Delivery systems improve antigen presentation by prolonging bioavailability and targeting lymph nodes or APCs.
• Novel adjuvant platforms show enhanced immune activation, offering alternatives to classical adjuvants.

Conclusions:

• Understanding adjuvant mechanisms is key to developing more effective vaccines.
• Both classical and novel adjuvant platforms offer distinct advantages for vaccine formulation.
• Future vaccine development requires careful consideration of adjuvant properties and potential challenges.